Works matching IS 20011326 AND DT 2025 AND VI 15 AND IP 1


Results: 55
    1
    2
    3
    4

    Annexin A8 deficiency delays atherosclerosis progression.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70176
    By:
    • Gutiérrez‐Muñoz, Carmen;
    • Blázquez‐Serra, Rafael;
    • San Sebastián‐Jaraba, Irene;
    • Sanz‐Andrea, Sandra;
    • Fernández‐Gómez, Maria J.;
    • Nuñez‐Moreno, Gonzalo;
    • Mínguez, Pablo;
    • Escolá‐Gil, Joan Carles;
    • Nogales, Paula;
    • Ollivier, Veronique;
    • Martín‐Ventura, Jose L.;
    • Ho‐Tin‐Noe, Benoit;
    • Rescher, Ursula;
    • Méndez‐Barbero, Nerea;
    • Blanco‐Colio, Luis M.
    Publication type:
    Article
    5

    Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70191
    By:
    • Wu, Zheng;
    • Ye, Qing;
    • Zhang, Shan;
    • Hu, Li‐Peng;
    • Wang, Xiao‐Qi;
    • Yao, Lin‐Li;
    • Zhu, Lei;
    • Xiao, Shu‐Yu;
    • Duan, Zong‐Hao;
    • Zhang, Xue‐Li;
    • Jiang, Shu‐Heng;
    • Zhang, Zhi‐Gang;
    • Liu, De‐Jun;
    • Li, Dong‐Xue;
    • Yang, Xiao‐Mei
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR‐mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70149
    By:
    • Wu, Shang‐Gin;
    • Ho, Chao‐Chi;
    • Yang, James Chih‐Hsin;
    • Yu, Shu‐Han;
    • Lin, Yen‐Feng;
    • Lin, Shu‐Chin;
    • Liao, Bin‐Chi;
    • Yang, Ching‐Yao;
    • Lin, Yen‐Ting;
    • Yu, Chong‐Jen;
    • Chuang, Ya‐Ting;
    • Liao, Wei‐Yu;
    • Yap, Kah Yi;
    • Kou, Weng Si;
    • Shih, Jin‐Yuan
    Publication type:
    Article
    45
    46
    47
    48

    Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 1, p. 1, doi. 10.1002/ctm2.70140
    By:
    • Lam, Pui Yeng;
    • Omer, Natacha;
    • Wong, Josh K. M.;
    • Tu, Cui;
    • Alim, Louisa;
    • Rossi, Gustavo R.;
    • Victorova, Maria;
    • Tompkins, Hannah;
    • Lin, Cheng‐Yu;
    • Mehdi, Ahmed M.;
    • Choo, Amos;
    • Elliott, Melissa R.;
    • Coleborn, Elaina;
    • Sun, Jane;
    • Mercer, Timothy;
    • Vittorio, Orazio;
    • Dobson, Lachlan J.;
    • McLellan, Alexander D.;
    • Brooks, Andrew;
    • Tuong, Zewen Kelvin
    Publication type:
    Article
    49
    50